Elite Pharmaceuticals Inc (ELTP)

[WeeZuhl]

Elite's CEO has no intention of taking steps to increase the share price or reach the Nasdaq. The intellectual patents for ART are currently worthless because no products using the technology have been approved and marketed. The CEO and other board members who are paid and bonus compensated in shares are very content with a .05 share price. This allows them to receive far more shares as payment then if the price was significantly higher. They are content fleecing the remaining 500m shares from the company while marketing some generic products that do add some overall value to the company. They will then sell the business to a larger company for maybe
20 or .25 a share giving them 5x their current salary and compensation that is paid in shares. Of course their final cost average will dictate their profit margin. They are just fleecing it dry without consideration to current shareholders. Now if shareholder current cost average is under .20 then the shareholder will make a little money.

This is close to how I see it, except the current board members are just compliant puppies, not principals. Nasrat was installed by the former board members from Epic, and he is a member of Epic Investments (so is Carter Ward, according to Dianne Will). In my opinion, this cabal and their New Jersey pharma bros (i.e. Nostrum) will use whatever tactics are necessary to extract value from the company and keep the share price in the single digits as they continue to accumulate their ownership. It's the ludicrosity of the tactics that makes the plan so obvious: Epic sitting on the generics for years; dumping the brand new opioids for pennies; quitting SequestOx at the finish line in order to forsake the 2 bead system; paying Nasrat millions of shares every year **just for the interest payments** on his yard sale loser trimipramine.


The cabal has zero concern for common shareholders, other than trying to shake loose their shares. The hope is that at some point they will have their bellies full of free and five cent shares and will decide to let the thing run a little before selling it off. Until then, Nasrat will continue to use Mikah as a blunt force weapon against common shareholders, maybe for as long as he is allowed, probably for as long as shareholders continue to let him.